TY - JOUR
T1 - Screening Donated Blood and Plasma for HTLV-III Antibody
T2 - Facing More Than One Crisis?
AU - Osterholm, Michael T.
AU - Bowman, Robert J.
AU - Chopek, Michael W.
AU - Mccullough, J. Jeffrey
AU - Korlath, Jack A.
AU - Polesky, Herbert F.
PY - 1985/5/2
Y1 - 1985/5/2
N2 - Little question remains that the causative agent of the acquired immunodeficiency syndrome (AIDS) is the newly recognized retrovirus, human T-cell lymphotropic virus Type III (HTLV-III).1 2 3 4 5 AIDS, the AIDS-related complex, and asymptomatic HTLV-III infection have been associated with several well-defined high-risk groups, including recipients of blood and blood products.6 7 8 Protection of our nation's blood and plasma supply from HTLV-III contamination has been one of the highest public health priorities related to the AIDS epidemic. Studies of symptomatic and asymptomatic members of high-risk groups indicate that those who are infected with HTLV-III are also likely to be positive for HTLV-III antibody.3,9 10 11 Tests.
AB - Little question remains that the causative agent of the acquired immunodeficiency syndrome (AIDS) is the newly recognized retrovirus, human T-cell lymphotropic virus Type III (HTLV-III).1 2 3 4 5 AIDS, the AIDS-related complex, and asymptomatic HTLV-III infection have been associated with several well-defined high-risk groups, including recipients of blood and blood products.6 7 8 Protection of our nation's blood and plasma supply from HTLV-III contamination has been one of the highest public health priorities related to the AIDS epidemic. Studies of symptomatic and asymptomatic members of high-risk groups indicate that those who are infected with HTLV-III are also likely to be positive for HTLV-III antibody.3,9 10 11 Tests.
UR - http://www.scopus.com/inward/record.url?scp=0022260349&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022260349&partnerID=8YFLogxK
U2 - 10.1056/NEJM198505023121810
DO - 10.1056/NEJM198505023121810
M3 - Editorial
C2 - 2984568
AN - SCOPUS:0022260349
VL - 312
SP - 1185
EP - 1189
JO - New England Journal of Medicine
JF - New England Journal of Medicine
SN - 0028-4793
IS - 18
ER -
